No selling, no commission
We do not sell medicine, run a pharmacy, or take a cut of any purchase. There is no checkout on this site by design.
About us
Jivan — medicine access for everyone
An independent, non-commercial price-transparency project built so that no family abandons treatment because nobody told them an affordable same-salt equivalent existed.
Why Jivan exists
The active ingredient in a medicine does not change at a border. Its price does — sometimes by a factor of ten, sometimes by a factor of a hundred. Families in the United States and Europe routinely discover this only after months of rationing doses, skipping refills, or stopping treatment they could never afford in the first place.
Jivan was built to close that information gap. We are not a pharmacy and we do not sell anything. We maintain an open catalog of medicine pricing with explicit honesty labels, background lookups for medicines we don't yet list, and a research library that teaches people how to verify products, talk to their doctors about cost, and buy safely.
The platform is free to use, with no account requirement and no paywall, and is sustained by voluntary reader contributions plus clearly labelled display advertising where enabled.
Labels over promises
Verified data is marked as verified. Estimates are marked as estimates. Unavailable data is stated as unavailable — never dressed up.
Physician-first
Every pricing page pushes toward clinician involvement, and our safety guidance errs on the side of caution, especially for high-risk therapy.
Corrections in public
Errors are fixed visibly with updated review dates rather than edited silently.
How the work is organized
Jivan is run by a small team organized around four functions. We deliberately publish role descriptions rather than personal biographies for staff privacy — accountability lives at the organization level, and every piece of content passes the same review workflow regardless of who drafted it.
Pricing research
Collecting and cross-checking reference price ranges across markets, maintaining the anchor dataset, and running the re-review cycle on existing figures.
Clinical content review
Checking every guide against regulator-approved label information (FDA labels, EMA product information, WHO guidance) so clinical statements stay within what the evidence supports.
Editorial and plain language
Turning source material into articles a stressed, non-specialist reader can actually use: clear next steps, explicit limitations, and no padding.
Engineering and data integrity
Keeping the catalog fast and searchable across 24 locales, and maintaining the labeling system that keeps estimates visibly separate from verified data.
Reach the team
Our published standards
We hold ourselves to written, public standards. If we fall short of them, readers should be able to point at them and say so.